Related by context. All words. (Click for frequent words.) 70 p = .# [002] 67 CI = 64 r = 64 #.# df = 63 β = 63 Suicidal ideation 62 p = 61 % CI #.#-#.# [006] 61 MMSE score 61 CI -#.# 61 sd = 60 P ≤ 60 confidence interval CI 60 depressive symptoms 60 % CI #.#-#.# [004] 60 confidence interval #.#-#.# 59 % Confidence Interval 59 neurocognitive functioning 59 suicide attempters 59 % CI #.#-#.# [008] 59 psychosocial functioning 59 comorbid 59 premorbid 58 P = .# 58 % CI #.#-#.# [002] 58 MADRS score 58 internalizing disorders 58 nondepressed 58 alexithymia 58 ß = 58 affective disorders 58 posttreatment 58 affective psychoses 57 affective psychosis 57 ANOVA 57 statistically significant p = 57 subscales 57 % CI #.#-#.# [001] 57 poststroke 57 Montgomery Åsberg Depression 57 baseline HbA1c 57 euthymic 57 r2 = 57 comorbidity 57 serum estradiol 57 MetS 57 dysthymia 57 nonpsychotic 56 cognitive affective 56 venlafaxine XR 56 neuropsychological deficits 56 euthymic patients 56 depressive symptomatology 56 shorter telomere length 56 achieved statistical significance 56 z = 56 salivary cortisol 56 symptom severity 56 syndromal 56 #q# deletion syndrome 56 suicidal ideation 56 MMSE scores 56 psychiatric comorbidities 56 inattention hyperactivity 56 placebo p = 56 sociodemographic characteristics 56 hippocampal volume 56 % CI #.#-#.# [003] 55 -#.# p = 55 psychiatric morbidity 55 Neuropsychiatric Inventory NPI 55 = -#.# 55 Rating Scale MADRS 55 multivariable analysis 55 comorbid anxiety 55 comorbid depression 55 % CI #.#-#.# [007] 55 univariate analyzes 55 hippocampal volumes 55 subsyndromal 55 hyperactivity inattention 55 posttest 55 subthreshold 55 schizophrenia schizoaffective disorder 55 PANSS 54 subscale scores 54 Depressive symptoms 54 = #.#-#.# 54 BMI z 54 Cognitive behavioral 54 Brief Psychiatric 54 p = #.# [002] 54 statistically significant p 54 bivariate 54 HADS 54 interquartile range 54 postintervention 54 μmol L 54 plasma leptin 54 adjunctive ABILIFY 54 sociodemographic factors 54 hypoactive 54 HOMA IR 54 divalproex 54 WOMAC pain 54 Interpersonal psychotherapy 54 Univariate analysis 54 placebo p 54 laboratory abnormalities 54 depressive symptom 54 psychopathology 54 AOR = 54 depression suicidal ideation 53 comorbid psychiatric 53 confidence intervals CIs 53 mmHg p = 53 psychiatric comorbidity 53 x ULN 53 ADAS cog 53 chi ^ sup 53 GABRA2 53 Neuroticism 53 HT 2A 53 antenatal depression 53 comorbid substance 53 neuropsychological functioning 53 TEAEs 53 prefrontal cortical 53 5 HTTLPR 53 psychosocial variables 53 suicide ideation 53 univariate analysis 53 HAQ DI 53 Hazard Ratio HR 53 Montgomery Asberg Depression 53 Rating Scale BPRS 53 kappa = 53 FEV ^ sub 53 probands 53 ± SD 53 Irritability anxiety cognitive 53 intima media thickness 53 statistical significance p 53 neurocognition 53 pmol liter 53 nonobese 53 = -#.# df 53 YMRS 53 interpersonal psychotherapy 53 baseline FEV 53 -#.# ± [002] 53 dysthymic 53 attain statistical significance 53 comorbid disorders 53 mg p = 53 daytime alertness 53 HDRS 53 % CI #.#-#.# [005] 53 DQB1 * 53 APOE genotype 53 p ≤ 53 multivariate analyzes 53 CI #.#-#.# [001] 52 NNT = 52 autistic traits 52 SSRI SNRI 52 logistic regression model 52 multivariate adjustment 52 mg kg Hematide 52 SGRQ 52 nighttime awakenings 52 odds ratios ORs 52 PANSS scores 52 sensory gating 52 mania hypomania 52 -#.# mg dL [002] 52 linaclotide treated 52 mmol l 52 cortical thickness 52 covariate 52 extrapyramidal disorder 52 somatization 52 neurodevelopmental impairment 52 familial aggregation 52 callous unemotional traits 52 DSM IV diagnosis 52 isoprostane 52 Posttraumatic stress disorder 52 glycated hemoglobin levels 52 elevated ALT 52 ANCOVA 52 avoidant personality disorder 52 endometrial thickness 52 variance ANOVA 52 tertiles 52 CI #.#-#.# [002] 52 ADAS Cog 52 mIU L 52 interrater reliability 52 glycated hemoglobin HbA1c 52 internalizing behaviors 52 schizotypal 52 carotid IMT 52 SGPT 52 pg ml 52 nmol liter 52 somatoform disorders 52 univariate 52 highest tertile 52 log# copies mL 52 neurobehavioral 52 HbA 1c 52 QTcF 52 psychomotor 52 extrapyramidal symptoms 52 nonsignificant 52 HbA1C levels 52 neurocognitive 52 proband 52 neurocognitive function 51 p = #.# [004] 51 EQ 5D 51 androgen depletion 51 χ 51 #q#.# deletion syndrome 51 nonpsychiatric 51 psychoeducation 51 HbA 1c levels 51 cognitive behavioral 51 BPRS 51 schizophreniform disorder 51 diastolic hypertension 51 Depression Inventory 51 Prefrontal 51 Multivariate analyzes 51 tertile 51 rCBF 51 desvenlafaxine succinate 51 Suicidal thoughts 51 somatic symptoms 51 RLAI 51 CC genotype 51 akathisia 51 fasting insulin 51 creatinine ratio 51 nonsignificant difference 51 convergent validity 51 unipolar depression 51 annualized relapse 51 hyperarousal symptoms 51 noncognitive 51 laterality 51 adjunctive placebo 51 posttraumatic stress disorder 51 alanine aminotransferase 51 bivariate analyzes 51 rs# [004] 51 fractional anisotropy 51 extraversion 51 Personality disorders 51 subclinical cardiovascular disease 51 CORE OM 51 subscore 51 multivariable adjusted 51 Major depressive disorder 51 emotional lability 51 comorbid ADHD 51 intraobserver 51 amisulpride 51 tHcy 51 hippocampal atrophy 51 â ‰ ¥ 51 serum leptin 51 hypersomnia 51 DAT1 51 subscores 51 HbA 1C 51 Alzheimer Disease Assessment 51 chronicity 51 HAM D# 51 serum BDNF 51 Socioeconomic status 51 TAXUS p value 51 Personality traits 51 Baseline characteristics 51 Negative Syndrome 51 sociodemographic variables 51 QIDS SR 51 neurosensory 51 nmol 51 thyrotropin levels 51 0 & 50 morphometric vertebral fractures 50 perceptual reasoning 50 psychiatric diagnoses 50 impulsivity 50 COMT genotype 50 WCST 50 hyperactivity impulsivity 50 intraclass correlation coefficients 50 Comorbid 50 decrements 50 nondemented 50 neuroleptic 50 urinary cortisol 50 overt nephropathy 50 neuropsychological impairments 50 follicular phase 50 mild renal impairment 50 allele frequencies 50 -#.# ± [001] 50 biopsy Gleason 50 mmol L 50 SRBD 50 oxycodone CR 50 DSM IV Axis 50 postop 50 albumin excretion rate 50 Generalized anxiety disorder 50 posterior cingulate 50 NIHSS 50 hypoglycemic events 50 unpaired t 50 bipolar mania trials 50 Apgar scores 50 retest reliability 50 multivariable Cox 50 neurocognitive impairment 50 reach statistical significance 50 hyperarousal 50 covariates 50 mild renal insufficiency 50 MADRS 50 HBeAg negative patients 50 genotypic resistance 50 lumbar spine BMD 50 ADCS CGIC 50 -#.# log# copies mL 50 correlation coefficients 50 neurocognitive deficits 50 Index CDAI 50 non affective psychosis 50 apolipoprotein B 50 interindividual variability 50 Lumbar spine 50 mood lability 50 Cronbach alpha 50 Y BOCS 50 nonadherence 50 HIV uninfected 50 quetiapine risperidone 50 CVD mortality 50 serum ALT 50 HRQOL 50 affective disorder 50 log# IU mL 50 nmol L 50 lability 50 psychiatric inpatients 50 externalizing disorders 50 Neuropsychological 50 puerperal psychosis 50 PREZISTA r arm 50 urine albumin 50 Cronbach 50 p = #.# [003] 50 dyads 50 untreated psychosis 50 HbA1c levels 50 adenotonsillectomy 50 mg BID dose 50 spirometric 50 interobserver reliability 50 regression coefficient 50 self directedness 50 preoperative PSA 50 hip BMD 50 HRQoL 50 GH deficiency 50 tryptophan depletion 50 mg kg dose 50 left ventricular diastolic 50 dysthymic disorder 49 umol L 49 syndromic 49 arterial oxygen saturation 49 Comorbidity 49 tic severity 49 unmeasured confounders 49 parous women 49 PaO 2 49 frequent awakenings 49 mRNA expression 49 habitual snoring 49 % #gt 49 perseverative 49 suicidal behaviors 49 multiple linear regression 49 IQR 49 cognitive domains 49 bipolar affective disorder 49 behavioral disinhibition 49 circadian misalignment 49 somatic complaints 49 CIBIC + 49 extroversion agreeableness 49 substance induced psychosis 49 DAS# [002] 49 tic disorders 49 comorbid conditions 49 STRATEGY FOR AN OPEN 49 #q# deletion 49 MMSE 49 schizotypal personality disorder 49 heterozygotes 49 limiting generalizability 49 parkinsonian 49 interobserver 49 Edinburgh Postnatal Depression 49 tiagabine 49 hypochondriasis 49 se xual 49 psychiatric outpatients 49 serum concentrations 49 infliximab monotherapy 49 statistically significant 49 ADHD RS 49 hyperkinetic disorder 49 logistic regression analyzes 49 EDSS scores 49 maladjustment 49 Neuropsychiatric Inventory 49 meta analytic review 49 Mania Rating Scale 49 lowest tertile 49 psychostimulants 49 mu opioid 49 logistic regression analysis 49 alanine aminotransferase ALT 49 familial clustering 49 lymphopenia 49 nonfatal MI 49 bulimia nervosa 49 serum retinol 49 statistically significant predictor 49 Expanded Disability Status 49 genital arousal 49 amygdala reactivity 49 chi squared 49 albumin excretion 49 p = .# [001] 49 symptomatology 49 n = 49 UPDRS 49 #.#/#.# mm Hg [003] 49 neural correlates 49 PERMP 49 diathesis 49 oxygen desaturation 49 PSQI 49 TIMP 49 progesterone receptor negative 49 ejaculatory control 49 Cognitive behavioral therapy 49 anhedonia 49 irritability mood swings 49 Fasting blood glucose 49 Binge eating 49 HBeAg 49 NIH CPSI 49 Multivariate analysis 49 subclinical atherosclerosis 49 prednisone prednisolone plus 49 diabetes mellitus DM 49 Pathological gambling 49 SNP rs# [002] 49 postoperative AF 49 leukopenia 49 prostate gland mammary gland 49 psychomotor speed 49 somatization disorder 49 extraverts 49 ALT elevation 49 FDG uptake 49 nonexposed 49 psychobiological 49 statistically nonsignificant 49 placebo fluoxetine 49 bipolar disorders 49 NIHSS score 49 sociodemographic 49 ‰ ¥ 49 D2 receptor 49 onset diabetes mellitus 49 somatic symptom 49 dissociative symptoms 49 Excessive daytime sleepiness 49 rs# [003] 49 macroalbuminuria 49 clinicopathological features 49 preintervention 49 multiple logistic regression 49 CHD mortality 49 5 HT2A 49 echocardiographic parameters 49 dysbindin 49 ω 49 poststroke depression 49 prodromal symptoms 49 CIBIC plus 49 Subgroup analyzes 49 Bonferroni correction 49 seropositivity 49 electroencephalographic 49 pediatric bipolar disorder 48 ziprasidone 48 colorectal adenoma 48 psychodynamic psychotherapy 48 nmol l 48 neuropsychological impairment 48 ADCS ADL 48 liver histology 48 APOE ε4 48 perimenopausal women 48 Child Behavior Checklist 48 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 48 neuropsychiatric symptoms 48 hematologic toxicity 48 use disorders AUDs 48 EORTC QLQ C# 48 recurrent VTE 48 pmol L 48 hippocampal function 48 hemoglobin A1c HbA1c 48 comorbid psychiatric disorders 48 neutropenic fever 48 psychopathological symptoms 48 HER2 expression 48 advanced adenoma 48 postdischarge 48 allele frequency 48 physiological arousal 48 fluoxetine paroxetine 48 metabolic dysregulation 48 Hamilton Rating Scale 48 antidepressants fluoxetine 48 prolactin levels 48 impaired glucose metabolism 48 Scale cognitive subscale 48 HER2 overexpression 48 parkinsonism 48 Psychodynamic 48 IQR = 48 amnestic MCI 48 serum urate levels 48 autonomic dysfunction 48 REYATAZ r arm 48 impulsivity characteristic 48 abstinent alcoholics 48 apnea hypopnea index 48 lamotrigine 48 collected saliva samples 48 parasomnias 48 Index FSFI 48 Sociodemographic 48 mean baseline A1C 48 fasting triglyceride levels 48 prepregnancy 48 pyrexia mucositis sepsis febrile 48 aminotransferase levels 48 strongest predictors 48 PSA nadir 48 serum homocysteine 48 manic hypomanic 48 anemia hemoglobin 48 subsyndromal depression 48 psychodynamic therapy 48 aOR 48 nonadopted 48 moderately heritable 48 attention-deficit/hyperactivity disorder ADHD 48 Suicidal behavior 48 HRQL 48 virological response 48 ventromedial 48 #.#/#.# mmHg [001] 48 quetiapine 48 parietal cortices 48 EDSS score 48 PCWP 48 Symptom Checklist 48 dehydroepiandrosterone sulfate 48 Obsessive compulsive disorder OCD 48 comorbid diagnoses 48 hypomanic symptoms 48 severe hypoglycaemia 48 ADHD Rating Scale 48 coinfected patients 48 #.#-#.# p = 48 Selective serotonin reuptake inhibitors 48 T2DM 48 normotensive 48 generalized estimating 48 mRS 48 perioperative complications 48 Socio demographic 48 IIEF 48 5q 48 estimated GFR 48 serum IGF 48 mean baseline HbA1c 48 depressive disorders 48 ADHD symptoms 48 prodromal 48 nonautistic 48 Subgroup analysis 48 sub syndromal 48 episodic migraine 48 externalizing behaviors 48 CYP#D# genotype 48 prepubertal 48 antidepressant efficacy 48 tonsillar hypertrophy 48 Univariate 48 ejaculatory function 48 premenopause 48 aripiprazole 48 tolterodine ER 48 MAOA 48 = .# 48 Wilcoxon rank sum 48 attention-deficit/hyperactivity disorder 48 nondiabetic patients 48 DAS# scores 48 hyper IgE syndrome 48 urinary N telopeptide 48 biochemical relapse 48 affect lability 48 convulsive disorders 48 hypomanic episodes 48 serotonin reuptake inhibitors 48 clinically meaningful improvement 48 metabolite concentrations 48 catechol O methyltransferase 48 thiopurine 48 Pearson correlation coefficient 48 psychopathological 48 Hb A1c 48 repetitive stereotyped 48 antisocial traits 48 baseline A1C 48 posttraumatic 48 elevated LDL 48 CTNNB1 48 nondiabetic 48 mood swings irritability 48 mood disorders 48 intraclass correlation coefficient 48 DSM IV criteria 48 HPA axis 48 sociodemographics 48 causal pathway 48 generalized anxiety disorder GAD 48 cognitive functioning 48 visuomotor 48 neuroanatomical 48 highly heritable 48 placebo controlled dose escalation 48 Insulin sensitivity 48 psychotic symptoms 48 CIN2 + 48 dyspareunia 48 chlamydial infection 48 Tasigna prolongs 48 System IPSS 48 Stroop task 48 CONCERTA ® 47 rheumatoid factor 47 nonsuicidal self injury 47 meta regression 47 cortisol secretion 47 maturational 47 antidiabetic medications 47 neuropsychological 47 oppositional defiant disorder 47 -#.# USD JPY [002] 47 min -1 47 mL/min/#.# m 2 47 CLA supplementation 47 antipsychotic efficacy 47 cardiac autonomic 47 gene APOE 47 mood suicidal ideation 47 haematologic 47 receiving ISENTRESS 47 mU liter 47 impaired cognition 47 HAM D# scores 47 dapagliflozin plus 47 A1 allele 47 somnolence dizziness 47 % #lt ;/ 47 dopamine hypothesis 47 clomipramine 47 orthostatic hypotension cataracts 47 developmental trajectories 47 depression suicidal thoughts 47 HAMD 47 prosocial behavior 47 sedatives hypnotics 47 Visual Analogue Scale VAS 47 dyspnea 47 airway responsiveness 47 dysuria 47 serum triglyceride 47 subclinical hypothyroidism 47 serum cotinine 47 white matter hyperintensities 47 fructosamine 47 atypical neuroleptics 47 conditional logistic regression 47 diastolic BP 47 Oppositional Defiant Disorder 47 Replication NCS R 47 Mental disorders 47 urinary excretion 47 #OHD 47 homozygotes 47 tapentadol IR 47 Chronic ITP 47 mg TID 47 tranylcypromine 47 bothersome symptom 47 aged ≥ 47 kcal mol 47 mm Hg diastolic 47 mucosal inflammation 47 citalopram 47 multivariable logistic regression 47 Prostate specific antigen 47 Health Assessment Questionnaire 47 BMI ≥ 47 hypertension diabetes mellitus 47 Negative Symptoms 47 generalized epilepsy 47 ng dL 47 metformin monotherapy 47 carotid atherosclerosis 47 NNRTI resistance 47 neutrophil counts 47 erythrocyte sedimentation rate 47 sleep disturbances 47 TT genotype 47 hypophosphatemia 47 Poisson regression 47 strongest predictor 47 dopamine transporter gene 47 osteopenic 47 intact parathyroid hormone 47 abnormal lipid 47 serum HBV DNA 47 CR nPR 47 rhinoconjunctivitis 47 recurrent venous thromboembolism 47 methotrexate monotherapy 47 socioeconomic status SES 47 comorbidities 47 baseline serum creatinine 47 multivariate logistic regression 47 opioid naive 47 subthreshold depression 47 State Trait Anxiety 47 depression irritability 47 biobehavioral 47 ALSFRS R 47 corticosterone levels 47 daytime somnolence 47 arterial thickening 47 Fasting plasma glucose 47 hypomania 47 risperidone Risperdal 47 posttraumatic stress disorder PTSD 47 antidepressant monotherapy 47 Â ± 47 Scale PANSS 47 depression suicidality 47 Borderline personality 47 #,# methylenedioxymethamphetamine 47 coinfection 47 mEq L 47 dietary calcium intake 47 statistical significance p = 47 ski lls 47 ± 47 ml kg 47 dichotomized 47 neurodevelopmental outcomes 47 pulvinar 47 postnatally 47 nmol L. 47 inattention impulsivity 47 polysomnographic 47 temporal cortex 47 attention-deficit/hyperactivity 47 Posttraumatic stress disorder PTSD 47 baseline CD4 47 mean ± SEM 47 antisocial behaviors 47 T1DM 47 logistic regression 47 paranoid ideation 47 hypothalamic pituitary adrenal HPA 47 dysphoric 47 LAB GHRH 47 Rating Scale 47 lopinavir r arm 47 borderline personality disorder 47 statistically significant correlation 47 Endothelial function 47 lipid parameters 47 colorectal neoplasia 47 abnormal cytology 47 Operative mortality 47 lactate dehydrogenase 47 plasma cortisol 47 Unified Parkinson Disease 47 protein excretion 47 elevated depressive symptoms 47 EpCAM expression 47 neurocognitive dysfunction 47 neuropathy sensory 47 oppositional defiant 47 A1c levels 47 Structured Clinical 47 psychopathological disorders 47 tic disorder 47 adverse reactions incidence 47 Leydig cell 47 0 len = 47 AUC0 47 hypogonadal 47 neurologic abnormalities 47 multivariable adjustment 47 VMAT2 47 hyperactivity distractibility 47 subjective sleepiness 47 venlafaxine Effexor 47 clinically meaningful reductions 47 overnight polysomnography 47 baseline LDH 47 mmol 47 hypoglycaemic episodes 47 agitation irritability 47 OAB symptoms 47 hydroxyvitamin D levels 47 confounding variables 47 psychophysiological 47 elevated serum ALT 47 prolonged QT interval 47 dysarthria 47 dizygotic 47 pain catastrophizing 47 histologic subtype 47 macrovascular disease 47 schizophrenics 47 serum lipid 47 Antisocial personality 47 QRS duration 47 unrefreshing sleep 47 endophenotypes 47 imipramine 47 Score TOS 47 orofacial clefts 47 falling asleep stomachache 47 Hazard Ratio = 47 pg mL 47 QoL 47 Testosterone deficiency 47 generalizability 47 covariance 47 Symptom severity 47 oxcarbazepine 47 SCr 47 DAS# remission 47 serotonin norepinephrine reuptake inhibitors 47 ≥ 47 Interrater reliability 47 suicidality 47 cortical activation 47 socioeconomic deprivation 47 CLBP 47 prescribed antipsychotics 47 CrCl 47 General Psychiatry 47 ethnicity socioeconomic status 47 akinesia 47 circadian clock genes 47 activity MAOA 46 Clinical Psychiatry 46 HCV genotype 46 multivariate analysis 46 nortriptyline 46 locomotor activity 46 tumor histology 46 SUVmax 46 maladaptive behavior 46 Irritability 46 atopic asthma 46 predictive validity 46 acamprosate 46 SPM Rated PG 46 advanced neoplasia 46 opioid receptor 46 citalopram Celexa 46 serum uric acid 46 confusion disorientation 46 Socioeconomic factors 46 striatal 46 pentoxifylline 46 noncardiac 46 -#.# mg dL [001] 46 Erectile function 46 plasma folate 46 bipolar illness 46 μg liter 46 treatment emergent AEs 46 transaminase elevations 46 psychiatric disorders ATI 46 APTIVUS r 46 mol L 46 psychological distress 46 visceral adiposity 46 monozygotic twins 46 serum cotinine levels 46 thyroglobulin 46 logistic regression models 46 visuospatial 46 PLMS 46 Index CDAI score 46 #mg/day [001] 46 Agreeableness 46 Global Impression 46 mso footer margin 46 lispro 46 aspartate aminotransferase AST 46 5 HTTLPR genotype 46 lipid lowering medications 46 fasting glucose levels 46 glycated hemoglobin 46 allele 46 neurological abnormalities 46 personality disorders 46 symptom exacerbation 46 disulfiram 46 multivariable analyzes 46 serum folate 46 extrapyramidal side 46 cortical thinning 46 EEG abnormalities 46 Primary endpoints 46 apnea hypopnea 46 Somnolence 46 Sensitivity specificity 46 SSRI citalopram 46 inhibitory receptor 46 point Likert scale 46 prolactin elevation 46 fluoxetine 46 g dl 46 neurobehavioural 46 postinjury 46 kidney allograft 46 Apolipoprotein E 46 Sexual arousal 46 paroxetine sertraline 46 intermittent exotropia 46 nM 46 guideline concordant 46 F FDG PET 46 narcolepsy cataplexy 46 C1 INH deficiency 46 receiving VICTRELIS 46 delusions hallucinations 46 Mild cognitive impairment 46 Secondary endpoints include 46 lateralized 46 fluticasone salmeterol 46 psychosocial outcomes 46 State Examination MMSE 46 ECOG PS 46 PKC inhibitors 46 postoperative delirium 46 recurrent acute pancreatitis 46 Heritability 46 Å -1 46 Descriptive statistics 46 platelet reactivity 46 prefrontal brain 46 coronary microvascular